ATE241010T1 - Klonierung und expression von biologisch aktiver alpha-n-acetylgalaktosaminidase - Google Patents

Klonierung und expression von biologisch aktiver alpha-n-acetylgalaktosaminidase

Info

Publication number
ATE241010T1
ATE241010T1 AT91920591T AT91920591T ATE241010T1 AT E241010 T1 ATE241010 T1 AT E241010T1 AT 91920591 T AT91920591 T AT 91920591T AT 91920591 T AT91920591 T AT 91920591T AT E241010 T1 ATE241010 T1 AT E241010T1
Authority
AT
Austria
Prior art keywords
cloning
expression
biologically active
active alpha
acetyl galactosaminidase
Prior art date
Application number
AT91920591T
Other languages
English (en)
Inventor
Robert J Desnick
David F Bishop
Yiannis A Ioannou
Anne M Wang
Original Assignee
Sinai School Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinai School Medicine filed Critical Sinai School Medicine
Application granted granted Critical
Publication of ATE241010T1 publication Critical patent/ATE241010T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2465—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01049—Alpha-N-acetylgalactosaminidase (3.2.1.49)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91920591T 1990-10-24 1991-10-23 Klonierung und expression von biologisch aktiver alpha-n-acetylgalaktosaminidase ATE241010T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/602,608 US5382524A (en) 1990-10-24 1990-10-24 Cloning and expression of biologically active α-n-acetylgalactosaminidase
PCT/US1991/007872 WO1992007936A1 (en) 1990-10-24 1991-10-23 Cloning and expression of biologically active alpha-n-acetylgalactosaminidase

Publications (1)

Publication Number Publication Date
ATE241010T1 true ATE241010T1 (de) 2003-06-15

Family

ID=24412043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91920591T ATE241010T1 (de) 1990-10-24 1991-10-23 Klonierung und expression von biologisch aktiver alpha-n-acetylgalaktosaminidase

Country Status (7)

Country Link
US (2) US5382524A (de)
EP (2) EP0554385B1 (de)
AT (1) ATE241010T1 (de)
AU (1) AU8954791A (de)
CA (1) CA2094922A1 (de)
DE (1) DE69133263T2 (de)
WO (1) WO1992007936A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2042093C (en) * 1990-05-09 2002-12-24 Gyula Hadlaczky Cell line carrying an excess of mammalian centromeres
US5401650A (en) * 1990-10-24 1995-03-28 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active α-galactosidase A
CA2149641A1 (en) * 1992-11-18 1994-05-26 Randy M. Berka Methods for converting a, ab and b blood types to o blood type
EP0694081A4 (de) * 1993-03-26 1998-07-15 New York Blood Center Inc REKOMBINANTE -g(a)-N-ACETYLGALACTOSAMINIDASE UND c DNA KODIEREND FÜR DIESES ENZYM
US6461844B1 (en) * 1995-08-22 2002-10-08 The Board Of Trustees Of The University Of Arkansas Liver GalNAc-1-phosphate kinase
US20030033617A1 (en) 1996-04-10 2003-02-13 Gyula Hadlaczky Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US20020160970A1 (en) * 1996-04-10 2002-10-31 Gyula Hadlaczky Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6077697A (en) * 1996-04-10 2000-06-20 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6025155A (en) * 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
RU2141526C1 (ru) * 1998-06-17 1999-11-20 Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН ШТАММ БАКТЕРИЙ FLAVOBACTERIUM SP. - ПРОДУЦЕНТ α-N- АЦЕТИЛГАЛАКТОЗАМИНИДАЗЫ
AU2000236029A1 (en) * 1999-02-23 2000-09-14 Anne Chew Receptor isogenes: polymorphisms in the tissue necrosis factor receptor
US6537785B1 (en) 1999-09-14 2003-03-25 Genzyme Glycobiology Research Institute, Inc. Methods of treating lysosomal storage diseases
US6770468B1 (en) 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
EP1911837B1 (de) * 2000-09-28 2011-05-25 Bioriginal Food & Science Corp. FAD5-2, Mitglied der Desaturase-Familie und Verwendungen davon
US7767415B2 (en) 2001-09-25 2010-08-03 Velico Medical, Inc. Compositions and methods for modifying blood cell carbohydrates
US6905856B2 (en) * 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
US6800472B2 (en) 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
US20030124652A1 (en) * 2001-12-21 2003-07-03 Novazyme Pharmaceuticals, Inc. Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells
AU2002357873A1 (en) * 2001-12-21 2003-07-15 Incyte Genomics, Inc. Carbohydrate-associated proteins
US8889127B2 (en) * 2004-07-01 2014-11-18 Icahn School Of Medicine At Mount Sinai Targeted protein replacement for the treatment of lysosomal storage disorders
NZ554824A (en) 2004-10-22 2010-10-29 Revivicor Inc Porcines that lack endogenous antibody chains and express exogenous immunoglobulins
GB0606190D0 (en) 2006-03-28 2006-05-10 Isis Innovation Construct
US8679478B2 (en) 2010-10-04 2014-03-25 Duke University Methods of lysosomal storage disease therapy
US10350277B2 (en) 2011-09-07 2019-07-16 Icahn School Of Medicine At Mount Sinai Ceramidase and cell differentiation
PL2854910T3 (pl) 2012-06-01 2020-07-27 Icahn School Of Medicine At Mount Sinai Poziomy ceramidu w leczeniu i zapobieganiu infekcjom
CA2905449C (en) 2013-03-14 2024-09-10 Icahn School Of Medicine At Mount Sinai THERAPEUTIC COMPOSITIONS OF ACID CERAMIDASE AND THEIR PROCESSES OF MANUFACTURE AND USE
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2017049157A1 (en) 2015-09-18 2017-03-23 Duke University Methods and compositions for the treatment of steatosis-associated disorders
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
EP4244360A4 (de) * 2020-11-16 2025-05-07 Beijing SoloBio Genetechnology Company Ltd. Rekombinante adeno-assoziierte viren mit erhöhtem lebertropismus und verwendungen davon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007573A1 (en) * 1988-12-23 1990-07-12 Genzyme Corporation Enzymatically active recombinant glucocerebrosidase
EP0463109A4 (en) * 1989-03-24 1992-11-19 Research Corporation Technologies, Inc. Recombinant alpha-galactosidase, a therapy for fabry disease

Also Published As

Publication number Publication date
EP0554385A1 (de) 1993-08-11
DE69133263D1 (de) 2003-06-26
US5491075A (en) 1996-02-13
EP0554385B1 (de) 2003-05-21
EP0554385A4 (en) 1994-08-17
EP1375665A1 (de) 2004-01-02
US5382524A (en) 1995-01-17
DE69133263T2 (de) 2004-04-08
CA2094922A1 (en) 1992-04-25
AU8954791A (en) 1992-05-26
WO1992007936A1 (en) 1992-05-14

Similar Documents

Publication Publication Date Title
ATE241010T1 (de) Klonierung und expression von biologisch aktiver alpha-n-acetylgalaktosaminidase
SE8802165D0 (sv) Improvements in and relating to fermentation
ATE86663T1 (de) Glucoamylasegen.
DE3684398D1 (de) Lipolytische enzyme und deren anwendung in reinigungsmitteln.
ES8802537A1 (es) Un procedimiento para preparar una celula huesped con un vector de expresion correspondiente a un activante de plasminogenos de tipo tejido modificado.
DE69111148D1 (de) Gärfutter-Enzymbehandlung.
DK0753057T3 (da) Alkalisk Bacillus-amylase
ATE43634T1 (de) Maltose erzeugendes amylase-enzymprodukt, dessen herstellung und dessen verwendung.
TR26942A (tr) Litik peptidler ve hidrolitik enzimler ihtiva eden anti-patojenik olarak etkili terkipler.
DK1022329T3 (da) Multienzymatisk sammensætning med glucoamylasisk, proteolytisk og xylanasisk aktivitet samt fremgangsmåde til fremstilling af sammensætningen ved hjælp af aspergillus-gæring i et fast hvedeklidsmedium
PT1318198E (pt) Processo para produzir um polipeptido recombinante que envolve a adicao de um inibidor de quimotripsina ao meio de cultura celular
ATE211163T1 (de) Verwendung eines kalksteindispergiermittels in einer waschmittelzusammensetzung enthaltend lipase enzyme
NO180643C (no) Alkalisk pullulanase Y med <alfa>-amylaseaktivitet og en biologisk renkultur av Bacillus sp. mikroorganisme som produserer denne
AU7037987A (en) Oxygen generating herbicides synergized with detoxifying enzyme inhibitor
DE69016693D1 (de) Züchtung von transformierten Mikroorganismen.
IL90575A0 (en) Ab-011 antibiotics,their production and compositions containing them
DE69029811D1 (de) Rotavirus-typ-b-kulturen und deren verwendung
DK0403015T3 (da) Fremgangsmåde til dyrkning af celler
NO902039D0 (no) Fremgangsmaate ved dyrking av cellekulturer i bioreaktor.
ATE73841T1 (de) Lipolytische enzyme und deren anwendung in reinigungsmitteln.
UA12055A1 (uk) Поліуретаhова композиція
ATE229075T1 (de) Klonieren von superoxiddismutase und expression in mikroorganismen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties